News

A highly sensitive bone marrow test could double survival rates for some groups of younger adults with acute myeloid leukemia ...
AML patients in the trial who were treated with SENTI-202 experienced complete remission after not responding to prior ...
A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukemia ...
From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...
The 10-minute procedure identified signs of acute myeloid leukaemia (AML) returning in patients before it showed in blood ...
A new single-cell reference atlas of normal hematopoiesis has helped researchers identify novel acute myeloid leukemia cell ...
May Overcome Resistance to Azacitidine-Venetoclax Regimen and Trigger Apoptosis of TP53 Mutated AML CellsNEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ...
Researchers have developed a new gene expression atlas to map how abnormal differentiation of hematopoietic cells can lead to acute myeloid leukemia (AML).
Breeze Hunter thought she simply had a sinus infection she couldn’t kick. It was acute myeloid leukemia, a form of blood ...
A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukaemia (AML) by helping ...
A 51-year-old woman who took part in the trial says she feels "incredibly lucky" after a new test detected cancer when a ...
The new treatment, which uses a type of immune cell called natural killer cells, promoted complete remission in several ...